Fayed Omnia, van Griensven Martijn, Tahmasebi Birgani Zeinab, Plank Christian, Balmayor Elizabeth R
Institute of Molecular Immunology and Experimental Oncology-Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Ethris GmbH, 82152 Planegg, Germany.
Mol Pharm. 2021 Mar 1;18(3):1121-1137. doi: 10.1021/acs.molpharmaceut.0c01042. Epub 2021 Jan 25.
Osteointegration is one of the most important factors for implant success. Several biomolecules have been used as part of drug delivery systems to improve implant integration into the surrounding bone tissue. Chemically modified mRNA (cmRNA) is a new form of therapeutic that has been used to induce bone healing. Combined with biomaterials, cmRNA can be used to develop transcript-activated matrices for local protein production with osteoinductive potential. In this study, we aimed to utilize this technology to create bone morphogenetic protein 2 (BMP2) transcript-activated coatings for titanium (Ti) implants. Therefore, different coating methodologies as well as cmRNA incorporation strategies were evaluated. Three different biocompatible biomaterials were used for the coating of Ti, namely, poly-d,l-lactic acid (PDLLA), fibrin, and fibrinogen. cmRNA-coated Ti disks were assayed for transfection efficiency, cmRNA release, cell viability and proliferation, and osteogenic activity . We found that cmRNA release was significantly delayed in Ti surfaces previously coated with biomaterials. Consequently, the transfection efficiency was greatly improved. PDLLA coating improved the transfection efficiency in a concentration-dependent manner. Lower PDLLA concentration used for the coating of Ti resulted in higher transfection efficiency. Fibrin and fibrinogen coatings showed even higher transfection efficiencies compared to all PDLLA concentrations. In those disks, not only the expression was up to 24-fold higher but also the peak of maximal expression was delayed from 24 h to 5 days, and the duration of expression was also extended until 7 days post-transfection. For fibrin, higher transfection efficiencies were obtained in the coatings with the lowest thrombin amounts. Accordingly, fibrinogen coatings gave the best results in terms of cmRNA transfection. All biomaterial-coated Ti surfaces showed improved cell viability and proliferation, though this was more noticeable in the fibrinogen-coated disks. The latter was also the only coating to support significant amounts of BMP2 produced by C2C12 cells . Osteogenesis was confirmed using BMP2 cmRNA fibrinogen-coated Ti disks, and it was dependent of the cmRNA amount present. Alkaline phosphatase (ALP) activity of C2C12 increased when using fibrinogen coatings containing 250 ng of cmRNA or more. Similarly, mineralization was also observed that increased with increasing cmRNA concentration. Overall, our results support fibrinogen as an optimal material to deliver cmRNA from titanium-coated surfaces.
骨整合是种植体成功的最重要因素之一。几种生物分子已被用作药物递送系统的一部分,以改善种植体与周围骨组织的整合。化学修饰的mRNA(cmRNA)是一种新型治疗手段,已被用于诱导骨愈合。与生物材料结合,cmRNA可用于开发具有骨诱导潜力的转录激活基质,用于局部蛋白质生产。在本研究中,我们旨在利用该技术为钛(Ti)种植体创建骨形态发生蛋白2(BMP2)转录激活涂层。因此,评估了不同的涂层方法以及cmRNA掺入策略。三种不同的生物相容性生物材料用于Ti的涂层,即聚-d,l-乳酸(PDLLA)、纤维蛋白和纤维蛋白原。对cmRNA包被的Ti盘进行转染效率、cmRNA释放、细胞活力和增殖以及成骨活性测定。我们发现,在先前用生物材料包被的Ti表面,cmRNA释放显著延迟。因此,转染效率大大提高。PDLLA涂层以浓度依赖的方式提高了转染效率。用于Ti涂层的较低PDLLA浓度导致较高的转染效率。与所有PDLLA浓度相比,纤维蛋白和纤维蛋白原涂层显示出更高的转染效率。在那些盘片中,不仅表达高达24倍,而且最大表达峰值从24小时延迟到5天,表达持续时间也延长到转染后7天。对于纤维蛋白,在凝血酶量最低的涂层中获得了更高的转染效率。因此,就cmRNA转染而言,纤维蛋白原涂层给出了最佳结果